Effects of Transcranial Direct Current Stimulation and Manual Therapy on Musculoskeletal Pain in Adolescent Dancers
Effects of Non-invasive Brain Stimulation and Manual Therapy on Musculoskeletal Pain in Adolescent Dancers: A Three-Arm Randomized Controlled Trial
Adolescent dancers are at high risk of musculoskeletal pain due to repetitive, high-intensity training. Persistent pain may lead to kinesiophobia (fear of movement), which can further impair physical function according to the fear-avoidance model. Transcranial direct current stimulation (tDCS) has been used as a top-down intervention for musculoskeletal pain; however, it remains unclear whether its analgesic effect results from true neural stimulation or from contextual factors such as treatment expectation.
This three-arm, single-blind randomized controlled trial will enroll 24 adolescent dancers aged 13 to 18 years with musculoskeletal pain lasting at least 3 months. Participants will be randomly allocated, stratified by pain site, to (1) active tDCS plus manual therapy, (2) sham tDCS plus manual therapy, or (3) sham tDCS plus manual therapy plus structured expectation-enhancement education. Each participant will receive a single intervention session. Outcomes will be assessed before, immediately after, and 1 week after the intervention. The study aims to distinguish the neurophysiological effect of tDCS from the effect of treatment expectation on pain, kinesiophobia, and related outcomes.
Studienübersicht
Status
Bedingungen
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Hyunjoong Kim, PhD
- Telefonnummer: +82-62-958-7598
- E-Mail: hjkim@ghu.ac.kr
Studienorte
-
-
-
Gwangju, Südkorea
- Jin's Ballet Academy, Pulse Dance Academy
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Adolescent dancers or dance majors aged 13 to 18 years
- Musculoskeletal pain in a specific body region (e.g., lower back, ankle) for at least 3 months
- Understanding of the study purpose and voluntary assent from the participant, with written informed consent from a legal guardian
Exclusion Criteria:
- Metal implants in the head or implanted electronic devices (e.g., cardiac pacemaker)
- Current pregnancy
- Current use of psychiatric medication
- Acute inflammatory disease
- Bleeding disorder or current use of anticoagulants
- Recent trauma, surgery, or skin disease at the painful (measurement) site
- History of epilepsy
- Any other physical condition that makes participation in the study or intervention inappropriate
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Active tDCS + Manual Therapy (ANT)
|
Anodal tDCS delivered at 2 mA for 20 minutes using saline-soaked sponge electrodes, with the anode over the primary motor cortex (C3/C4) and the cathode over the contralateral frontal area according to the international 10-20 system. Current is ramped up and down gradually. Manual therapy including instrument-assisted soft tissue mobilization (Graston technique) applied to the painful region for 15 minutes, with the tool held at 30 to 60 degrees, within a tolerable pain range (VAS 3 to 4). |
|
Schein-Komparator: Sham tDCS + Manual Therapy (SCT)
|
Manual therapy including instrument-assisted soft tissue mobilization (Graston technique) applied to the painful region for 15 minutes, with the tool held at 30 to 60 degrees, within a tolerable pain range (VAS 3 to 4). Identical electrode placement and procedure as active tDCS for 20 minutes, with current delivered only for the first 30 seconds and then turned off. |
|
Experimental: Sham tDCS + Manual Therapy + Expectation-Enhancement Education (ECT)
|
Manual therapy including instrument-assisted soft tissue mobilization (Graston technique) applied to the painful region for 15 minutes, with the tool held at 30 to 60 degrees, within a tolerable pain range (VAS 3 to 4). Identical electrode placement and procedure as active tDCS for 20 minutes, with current delivered only for the first 30 seconds and then turned off. A 5- to 10-minute structured education session delivered by the investigator using a standardized script that explains the principles and expected effects of the treatment. |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Pain Intensity (Numeric Pain Rating Scale, NPRS)
Zeitfenster: Baseline (before intervention), immediately after intervention, and 1 week after intervention
|
Pain intensity rated on a 0 to 10 scale (0 = no pain, 10 = worst pain imaginable). Higher scores indicate greater pain. |
Baseline (before intervention), immediately after intervention, and 1 week after intervention
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Hyunjoong Kim, PhD, Gwangju Health University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Schmerzen
- Neurologische Manifestationen
- Erkrankungen des Bewegungsapparates
- Muskelerkrankungen
- Psychische Störungen
- Phobische Störungen
- Angststörungen
- Pathologische Zustände, Anzeichen und Symptome
- Anzeichen und Symptome
- Kinesiophobie
- Muskel-Skelett-Schmerzen
- Chronischer Schmerz
- Therapeutika
- Komplementäre Therapien
- Physiotherapiemodalitäten
- Rehabilitation
- Muskuloskelettmanipulationen
Andere Studien-ID-Nummern
- 1040198-260618-HR-137-04
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .